38 results on '"Tetzlaff, Michael T."'
Search Results
2. Phenotypic switch in mycosis fungoides: A tertiary cancer center experience
3. Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma
4. Dermatopathology in the Molecular Age
5. Dermatopathology
6. Prognostic significance of acral lentiginous histologic type in T1 melanoma
7. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
8. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis
9. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis
10. Without Missing a Beat: Absence of Cilia Informs the Diagnosis of Histopathologically Challenging Spitzoid Melanocytic Neoplasms
11. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features
12. Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma
13. The evolving landscape of HPV-related neoplasia in the head and neck
14. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
15. Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes
16. Update on sebaceous neoplasia: the morphologic spectrum and molecular genetic drivers of carcinoma
17. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma
18. Intratumoral and peritumoral lymphovascular invasion detected by D2-40 immunohistochemistry correlates with metastasis in primary cutaneous Merkel cell carcinoma
19. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers
20. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
21. Differential expression of CCR4 in primary cutaneous gamma/delta (γ⁄δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy
22. Merkel cell carcinoma with fingolimod treatment for multiple sclerosis: A case report
23. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms
24. Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
25. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma
26. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions
27. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors
28. Epithelial, non-melanocytic and melanocytic proliferations of the ocular surface
29. BRAF inhibitor therapy–associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression
30. A Single-Center Experience With Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma
31. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin
32. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes
33. T-Cell Receptor-γ in Gamma-Delta Phenotype Cutaneous T-Cell Lymphoma Can Be Accompanied by Atypical Expression of CD30, CD4, or TCRβF1 and an Indolent Clinical Course
34. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature
35. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma
36. miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
37. Loss of microRNA-205 expression is associated with melanoma progression
38. Fluorescent in situ hybridization of a skin biopsy: An adjunctive tool to support a diagnosis of graft-versus-host disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.